Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer
Clinical trial NCT04870034 · WITHDRAWN
Trial details
- NCT number
- NCT04870034
- Sponsor
- Roswell Park Cancer Institute
- Status
- WITHDRAWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-15
- Primary completion
- 2025-09-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.